scabies
SCABIES
Scabies is a contagious disease caused by the mite Sarcoptes scabiei var hominis.
The affected individual usually complains of having a highly pruritic rash that occurs at night.
It occurs more often in children <15 years of age, sexually active young adults, the immunocompromised and in persons living in crowded living conditions (eg nursing homes, military barracks).
Transmission is typically by direct skin contact with an infected person and in adults, sexual transmission is common.

Prevention

Crusted Scabies

Control of Disease Dissemination

  • In the case of crusted scabies there is an increased risk of transmission to contact persons
    • Strict isolation of the patient should be observed until cure is achieved
    • Avoidance of direct skin contact: Use of gloves & gowns by hospital staff
    • Careful washing of the patient’s clothes, linens & towels, etc
  • Both low & high risk patient contacts should be treated
    • High-risk contacts: Persons w/ protracted or frequent skin contact (eg via the hands) w/ the infected individual should be treated regardless of the presence of symptoms
    • Low risk contacts: Persons w/ indirect contact (eg via bedding) to the infected individual only need treatment in the case of crusted scabies
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
13 Aug 2019
Individuals with obesity are at an elevated risk of developing infections, particularly that of the skin in both men and women, and those of the gastrointestinal and urinary tracts and sepsis in women only, according to a study.
5 days ago
An increase in intensive care unit (ICU) management and bacterial pneumonia development occurs in children with special risk medical conditions (SRMC), but a rise in the probability of death or need for mechanical ventilation remains inconsistent, suggests a recent study.
Pearl Toh, 30 Aug 2019
Oral amoxicillin–clavulanate effectively promotes resolution of nonsevere acute exacerbations in children with non-cystic fibrosis (CF) bronchiectasis, thus confirming the role of amoxicillin–clavulanate as first-line treatment for bronchiectasis, according to results from the three-arm BEST-1 study.